Abstract
Digital breast tomosynthesis (DBT) has shown improved breast cancer detection and reduction in recall rates in comparison to full-field digital mammography on many recent clinical trials. This article will provide an analysis of some of the DBT research to date regarding the benefits this technology affords for breast cancer detection, as well as review recent DBT technology updates, such as the synthetic view (C-view) and DBT-guided biopsy. This article will assess the current utilization of DBT for breast cancer screening, as well as its use in the diagnostic evaluation of breast disease. The limitations of the technology, such as the visualization and characterization of calcifications, will be discussed, as well as how the technology may change in the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
